Projected Income Statement: Incyte Corporation

Forecast Balance Sheet: Incyte Corporation

Fiscal Period: December 2021 2022 2023 2024 2025 2026 2027 2028
Net Debt 1 -2,348 -3,239 -3,656 -2,158 -3,098 -4,230 -5,991 -7,970
Change - -37.95% -12.87% 40.97% -43.56% -36.55% -41.63% -33.03%
Announcement Date 08/02/22 07/02/23 13/02/24 10/02/25 10/02/26 - - -
1USD in Million
Estimates

Cash Flow Forecast: Incyte Corporation

Fiscal Period: December 2021 2022 2023 2024 2025 2026 2027 2028
CAPEX 1 181 77.83 32.49 86.26 58.87 74.91 77.22 85.7
Change - -57% -58.26% 165.54% -31.76% 27.26% 3.08% 10.98%
Free Cash Flow (FCF) 1 568.5 892.1 464 249.1 - 676.2 1,633 1,749
Change - 56.93% -47.99% -46.32% - - 141.43% 7.16%
Announcement Date 08/02/22 07/02/23 13/02/24 10/02/25 10/02/26 - - -
1USD in Million
Estimates

Forecast Financial Ratios: Incyte Corporation

Fiscal Period: December 2021 2022 2023 2024 2025 2026 2027 2028

Profitability

        
EBITDA Margin (%) 21.55% 17.61% 19.03% 11.86% 33.25% 12.91% 33.94% 30.41%
EBIT Margin (%) 19.62% 17.07% 16.79% 9.76% 31.43% 14.54% 36.33% 38.68%
EBT Margin (%) 19.1% 15.59% 22.57% 7.47% 32.37% 11.92% 31.39% 32.25%
Net margin (%) 31.76% 10.04% 16.17% 0.77% 25.03% 7.84% 23.88% 25.83%
FCF margin (%) 19.04% 26.28% 12.56% 5.87% - 11.38% 26.06% 26.65%
FCF / Net Income (%) 59.93% 261.88% 77.64% 763.68% - 145.16% 109.14% 103.15%

Profitability

        
ROA 22.34% 6.32% 9.47% 3.72% 22.02% 7.55% 19.13% 16.62%
ROE 29.73% 8.37% 12.5% 5.27% 31.7% 9.28% 25.02% 21.21%

Financial Health

        
Leverage (Debt/EBITDA) - - - - - - - -
Debt / Free cash flow - - - - - - - -

Capital Intensity

        
CAPEX / Current Assets (%) 6.06% 2.29% 0.88% 2.03% 1.14% 1.26% 1.23% 1.31%
CAPEX / EBITDA (%) 28.12% 13.02% 4.62% 17.15% 3.44% 9.77% 3.63% 4.29%
CAPEX / FCF (%) 31.84% 8.72% 7% 34.63% - 11.08% 4.73% 4.9%

Items per share

        
Cash flow per share 1 3.375 4.331 2.198 1.593 7.043 3.101 9.783 -
Change - 28.32% -49.26% -27.52% 342.16% -55.98% 215.53% -
Dividend per Share 1 - - - - - - - -
Change - - - - - - - -
Book Value Per Share 1 16.98 19.62 23.14 17.82 26.04 29.28 38.83 49.2
Change - 15.57% 17.94% -22.97% 46.09% 12.44% 32.64% 26.7%
EPS 1 4.27 1.52 2.65 0.15 6.41 2.241 7.239 7.859
Change - -64.4% 74.34% -94.34% 4,173.33% -65.04% 223.05% 8.57%
Nbr of stocks (in thousands) 220,891 222,475 224,109 192,650 196,323 202,698 202,698 202,698
Announcement Date 08/02/22 07/02/23 13/02/24 10/02/25 10/02/26 - - -
1USD
Estimates
2026 *2027 *
P/E 57.2x 17.7x
PBR 4.38x 3.3x
EV / Sales 3.66x 3.19x
Yield - -

EPS & Dividend



Y-o-Y evolution of P/E

 

Year-on-year evolution of the Yield

Trader
Investor
Global
Quality
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
28
Last Close Price
128.12USD
Average target price
127.12USD
Spread / Average Target
-0.78%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. INCY Stock
  4. I1NC34 Stock
  5. Financials Incyte Corporation